A specific probiotic strain called Lactiplantibacillus plantarum HOKKAIDO significantly improved survival and reduced virus levels in mice exposed to respiratory infection, according to research reviewed by Gram. In the study, mice receiving the probiotic before viral exposure had substantially lower lung virus levels and preserved immune cells called alveolar macrophages, which normally get destroyed by respiratory viruses. The probiotic worked by protecting these critical immune cells, preventing excessive inflammation while maintaining the body’s ability to fight the infection. While these results are promising, this research was conducted in mice, and human studies are needed before recommending this probiotic for respiratory infection prevention in people.
Researchers discovered that a specific probiotic strain called Lactiplantibacillus plantarum HOKKAIDO may help protect against respiratory viral infections. In a study with mice, animals that received this probiotic before being exposed to a respiratory virus had better survival rates, lost less weight, and had lower virus levels in their lungs compared to untreated mice. The probiotic worked by protecting special immune cells in the lungs called alveolar macrophages, which are the body’s first line of defense against respiratory viruses. According to Gram Research analysis, this finding suggests probiotics could become an important preventive tool against respiratory diseases in animals and potentially humans.
Key Statistics
A 2026 research study found that mice treated with Lactiplantibacillus plantarum HOKKAIDO probiotic had significantly higher survival rates and substantially lower respiratory virus levels in their lungs compared to untreated mice exposed to Sendai virus.
According to research published in Frontiers in Immunology in 2026, the probiotic-treated mice maintained normal numbers of alveolar macrophages (protective lung immune cells) after viral infection, while untreated mice experienced significant loss of these critical immune cells.
A 2026 study demonstrated that removing alveolar macrophages from mice completely eliminated the probiotic’s protective effect against respiratory infection, proving these immune cells are essential for the probiotic’s antiviral benefits.
The Quick Take
- What they studied: Whether a specific probiotic bacteria could protect mice from getting sick with a respiratory virus and how it worked to provide that protection.
- Who participated: Laboratory mice (DBA/2 strain) that were given either the probiotic or a control substance before being exposed to Sendai virus, a respiratory infection similar to some human viruses.
- Key finding: Mice that received the probiotic had significantly better survival rates, less weight loss, and much lower virus levels in their lungs compared to mice that did not receive the probiotic.
- What it means for you: This research suggests that probiotics might help prevent or reduce the severity of respiratory infections, though this study was done in mice and more research in humans is needed before drawing firm conclusions.
The Research Details
Researchers conducted an experiment using laboratory mice to test whether a probiotic called Lactiplantibacillus plantarum HOKKAIDO could protect against respiratory viral infection. The mice were divided into two groups: one group received the probiotic by mouth for 7 days, while the other group received a placebo (inactive substance). After this preparation period, both groups were exposed to Sendai virus through their nose to simulate a natural respiratory infection.
The researchers then carefully monitored what happened to the mice over the following days. They measured how many mice survived, how much weight each mouse lost, how much virus was present in the lungs, and what immune responses occurred in the respiratory tract. They also examined specific immune cells and chemical signals in the lungs to understand how the probiotic was working.
To prove that the probiotic’s protective effect depended on specific immune cells called alveolar macrophages, the researchers performed an additional experiment where they removed these cells from mice before giving them the probiotic. This helped confirm that these particular immune cells were essential for the probiotic’s protective benefits.
Understanding how probiotics work to fight infections is important because it helps scientists develop better preventive strategies against respiratory diseases. This research approach, which combines observations of survival and disease severity with detailed examination of immune mechanisms, provides strong evidence that the probiotic’s benefits are real and not just coincidental. By identifying the specific immune cells responsible for protection, researchers can better predict whether this probiotic might work in other situations and potentially in other species.
This study was published in Frontiers in Immunology, a peer-reviewed scientific journal, which means other experts reviewed the research before publication. The researchers used a controlled experimental design with clear comparison groups, which is a strong approach for establishing cause and effect. The study included multiple measurements of different outcomes, which strengthens confidence in the findings. However, because this research was conducted in mice rather than humans, results may not directly apply to people without further testing.
What the Results Show
Mice that received the probiotic before viral infection showed dramatically better outcomes than untreated mice. The probiotic-treated mice had significantly higher survival rates and experienced less weight loss during the infection. Most importantly, when researchers measured virus levels in the lungs at 7 days after infection, they found that probiotic-treated mice had substantially lower amounts of virus compared to control mice.
The protective mechanism became clear when researchers examined immune cells in the lungs. In untreated mice, the respiratory virus caused a significant decrease in the number of alveolar macrophages, special immune cells that normally protect the lungs. However, in mice that received the probiotic, these protective immune cells were preserved and remained at normal levels even after viral infection. This preservation of immune cells appears to be a key reason why the probiotic-treated mice fared better.
The probiotic also reduced excessive inflammation in the lungs. While some inflammation is necessary to fight infection, too much inflammation can damage lung tissue and make illness worse. Mice receiving the probiotic had lower levels of inflammatory chemicals in their lungs, suggesting the probiotic helped the immune system fight the virus without causing excessive damage.
To confirm that alveolar macrophages were truly responsible for the probiotic’s benefits, researchers depleted these cells in mice before administering the probiotic. When these immune cells were removed, the probiotic no longer provided protection, proving that these cells are essential for the probiotic’s antiviral effects.
The probiotic also caused changes in the gut bacteria composition of treated mice, including increased diversity of bacterial species and altered abundance of specific bacterial types. These changes in the gut microbiome may contribute to the overall immune-boosting effects, though the exact role of these changes requires further investigation. The findings suggest that probiotics work through multiple pathways: directly affecting gut bacteria and also triggering systemic immune responses that extend to the respiratory tract.
This research builds on the researchers’ earlier work showing that the same probiotic strain reduced intestinal disease and diarrhea in calves infected with rotavirus. The current study extends these findings by demonstrating that the probiotic’s benefits are not limited to intestinal infections but can also protect against respiratory infections in a different animal model. This consistency across different infection types and species suggests the probiotic has broad immune-enhancing properties. The findings align with growing scientific evidence that gut health and immune function are closely connected, and that probiotics can influence immune responses throughout the body, not just in the digestive system.
This study was conducted in laboratory mice, which have different immune systems and living conditions than humans or farm animals. Results from mouse studies do not always translate directly to people or other species. The study did not specify the exact number of mice used in each group, making it difficult to assess the statistical power of the findings. The research examined only one probiotic strain and one respiratory virus, so it is unclear whether these results would apply to other probiotic strains or different respiratory viruses. Additionally, the study did not test whether the probiotic would work if given after infection had already started, only as a preventive measure given before exposure. Finally, the mechanisms identified in this mouse study may not fully explain how the probiotic works in more complex biological systems like humans.
The Bottom Line
Based on this research, the probiotic Lactiplantibacillus plantarum HOKKAIDO shows promise as a preventive strategy against respiratory viral infections. However, because this study was conducted in mice, recommendations for human use cannot be made at this time. Further research in larger animals and eventually in humans would be needed before this probiotic could be recommended for preventing respiratory infections in people. For now, this research provides a strong scientific foundation for future clinical trials. The evidence quality is moderate to good for animal studies, as the research used controlled conditions and measured multiple relevant outcomes.
This research is most immediately relevant to the cattle industry, where respiratory infections cause significant economic losses in young calves. Veterinarians and livestock producers should follow future research on this probiotic for potential use in animal health. Scientists and immunologists interested in how probiotics work should find this research valuable. People interested in preventive health strategies and natural approaches to infection prevention may find this research interesting, though they should understand that human studies are still needed. This research is less relevant to people currently suffering from active respiratory infections, as the probiotic was tested only as a preventive measure, not as a treatment for existing illness.
In the mouse study, protective effects were observed within 7 days of infection. However, the probiotic was given for 7 days before exposure to the virus, suggesting that building up the protective effect takes time. For practical application, people would likely need to take the probiotic regularly for several days or weeks before expecting protective benefits. The timeline for seeing benefits in humans, if this probiotic is eventually tested in people, may differ from what was observed in mice.
Frequently Asked Questions
Can probiotics help prevent respiratory infections like colds and flu?
Research in mice shows that Lactiplantibacillus plantarum HOKKAIDO probiotic reduced respiratory virus levels and improved survival, suggesting probiotics may help prevent respiratory infections. However, human studies are still needed to confirm whether this works in people.
How do probiotics protect against lung infections?
This research shows the probiotic protects special immune cells in the lungs called alveolar macrophages, which normally get destroyed by respiratory viruses. By preserving these cells, the probiotic helps the lungs fight infection more effectively while reducing harmful inflammation.
Should I take probiotics to prevent getting sick with respiratory viruses?
While this mouse study is promising, human research is still needed before recommending probiotics specifically for respiratory infection prevention. Talk to your doctor about whether probiotics might be appropriate for your individual health situation.
What is Lactiplantibacillus plantarum HOKKAIDO and where can I find it?
This is a specific strain of beneficial bacteria studied for its immune-boosting properties. It is not yet widely available in commercial probiotic products. Researchers are still testing whether it works in humans before it becomes available to consumers.
Can probiotics treat respiratory infections that have already started?
This study tested the probiotic only as a preventive measure given before viral exposure, not as a treatment for active infection. Whether probiotics help treat existing respiratory infections requires separate research.
Want to Apply This Research?
- Users interested in probiotic supplementation could track daily probiotic intake and monitor respiratory health metrics such as frequency of colds or respiratory infections, severity of symptoms when illness occurs, and recovery time. This personal tracking could help users identify whether probiotics correlate with improved respiratory health in their individual experience.
- Users could establish a daily habit of taking a probiotic supplement, particularly during seasons when respiratory infections are more common. The app could send reminders for consistent daily intake and provide educational content about maintaining gut health through diet and lifestyle factors that support beneficial bacteria.
- Over a period of several months, users could track the number of respiratory infections experienced, symptom severity using a simple scale, and how long recovery took. The app could generate reports comparing infection frequency before and after starting regular probiotic use, helping users identify personal patterns. Users should also note other factors like sleep, stress, and diet that influence immune function.
This research was conducted in laboratory mice and has not been tested in humans. Results from animal studies do not always apply directly to people. This article is for educational purposes and should not be considered medical advice. Anyone considering probiotic supplementation, especially those with compromised immune systems, pregnant women, or people taking medications, should consult with a healthcare provider before starting any new supplement. This research describes a single probiotic strain and does not apply to all probiotics. Do not use this information to self-treat or delay seeking professional medical care for respiratory infections.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.